Published: 2025-12-24 12:38
Winter Emollient Safety: MHRA and Fire Chiefs Council Urge Caution
What happened
As winter approaches, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) have issued a joint safety warning regarding the use of emollients. These products, commonly used to manage dry skin conditions such as eczema and psoriasis, have been identified as potential fire hazards when applied to the skin. The agencies are urging healthcare professionals and patients to exercise caution, particularly when using emollients in conjunction with heat sources, including radiators, electric blankets, and other heating devices.
Why it matters in the UK
The warning is particularly significant in the UK, where winter temperatures can lead to increased use of heating devices. Emollients are widely prescribed, especially for vulnerable populations such as children and the elderly. The combination of these products with heat sources raises the risk of fire incidents, which can have devastating consequences. The MHRA and NFCC aim to raise awareness among both healthcare providers and patients about the importance of safe usage practices, thereby reducing the risk of fire-related injuries.
Evidence & limitations
While the MHRA and NFCC have highlighted the potential risks associated with emollient use, specific data detailing the frequency of fire incidents related to these products remains limited. Anecdotal evidence suggests that there have been cases where emollients have ignited, particularly when patients are using them near open flames or hot surfaces. However, comprehensive studies quantifying these incidents are lacking, which makes it challenging to assess the full scope of the problem. Further research may be necessary to establish a clearer understanding of the risks involved.
Regulation & governance
The MHRA is responsible for ensuring that medicines and healthcare products are safe and effective for use in the UK. In collaboration with the NFCC, they are working to provide guidance that aligns with existing safety regulations. The National Institute for Health and Care Excellence (NICE) also plays a role in providing evidence-based recommendations for the use of emollients in clinical practice. Additionally, the Care Quality Commission (CQC) oversees the quality of care provided by health services, ensuring that patient safety is a priority. The integration of these regulatory bodies underscores the commitment to patient safety while addressing the risks associated with emollient use.
What happens next
In response to the safety warning, healthcare professionals are encouraged to review their prescribing practices and discuss the safe use of emollients with patients. Patients should be informed about the potential risks and advised on how to apply these products safely. The MHRA and NFCC plan to continue monitoring the situation and may issue further guidance as necessary. Additionally, educational campaigns may be developed to raise awareness among the public about the safe use of emollients during the winter months.
Key takeaways
- The MHRA and NFCC have issued a safety warning regarding the use of emollients during winter.
- Emollients can pose fire hazards when used near heat sources.
- Healthcare professionals should educate patients on the safe application of emollients.
- Limited evidence exists on the frequency of fire incidents related to emollient use.
- Regulatory bodies are committed to ensuring patient safety and may provide further guidance.
Source: Gov UK
